Zizhen Kang

2.5k citations
37 papers · 1.7k indexed · h-index 20
Topics
Cytokine Signaling Pathways and Interactions (10 papers)Psoriasis: Treatment and Pathogenesis (9 papers)Immune Response and Inflammation (6 papers)

In The Last Decade

Zizhen Kang

34 papers receiving 1.7k citations

Peers

Zizhen Kang
Comparison fields: 5 of 93
  • Immunology 986
  • Molecular Biology 540
  • Pathology and Forensic Medicine 273
  • Neurology 269
  • Oncology 259
Replace Franziska Petermann with:
Franziska Petermann Germany
Mohamed El Behi France
Paul T. Massa United States
John S. Tzartos Greece
Cornelia Cudrici United States
Shinji Oki Japan
Michio Fujiwara Japan
Robert H. Swanborg United States
Thaddeus Carlson United States
Sabine Ring Germany
Zizhen Kang relative to Franziska Petermann Germany Franziska Petermann's profile →
Citations per field
00.5×1.5×1.8×
Franziska Petermann · 1×
Citations per year

Countries citing papers authored by Zizhen Kang

Since Specialization
Citations

This map shows the geographic impact of Zizhen Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zizhen Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zizhen Kang more than expected).

Fields of papers citing papers by Zizhen Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zizhen Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zizhen Kang. The network helps show where Zizhen Kang may publish in the future.

Co-authorship network of co-authors of Zizhen Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Zizhen Kang. A scholar is included among the top collaborators of Zizhen Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zizhen Kang. Zizhen Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 7
3 17
4 15
5 5
6 129
7 24
8 25
9 83
10 123
11 172
12 59
13 87
14 62
15 155
16 93
17 235
18 110
19 45
20 35

About Zizhen Kang

Zizhen Kang is a scholar working on Immunology, Hematology and Oncology, having authored 37 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (10 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and Immune Response and Inflammation (6 papers). The work is most often cited by research in Immunology (986 citations), Neurology (269 citations) and Developmental Neuroscience (123 citations). Zizhen Kang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Xiaoxia Li, Caini Liu, Muhammet F. Gülen, Katarzyna Bulek, Richard M. Ransohoff, Qian Wen, Chenhui Wang, Shadi Swaidani, Vincent K. Tuohy and Cengiz Z. Altuntas. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026